Dysregulated upregulation of T-cell immunoglobulin and mucin domain-3 on mucosal T helper 1 cells in patients with Crohn's disease

Scandinavian Journal of Gastroenterology

Volumn 46, Issue 6, 2011, Pages 701-709

  Morimoto, Kenichi ^a   Hosomi, Shuhei ^a   Yamagami, Hirokazu ^a   Watanabe, Kenji ^a   Kamata, Noriko ^a   Sogawa, Mitsue ^a   MacHida, Hirohisa ^a   Okazaki, Hirotoshi ^a   Tanigawa, Tetsuya ^a   Nagahara, Hisashi ^a   Noda, Eiji ^a   Tominaga, Kazunari ^a   Watanabe, Toshio ^a   Fujiwara, Yasuhiro ^a   Maeda, Kiyoshi ^a   Hirakawa, Kosei ^a   Arakawa, Tetsuo ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Crohn's disease; galectin 9; inflammatory bowel disease; T cell immunoglobulin and mucin domain 3 (TIM 3)

Indexed keywords

ECALECTIN; IMMUNOGLOBULIN; MESSENGER RNA; MUCIN 3; T CELL IMMUNOGLOBULIN AND MUCIN DOMAIN 3; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CELL; CELL ISOLATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENDOSCOPIC BIOPSY; ENTERITIS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNE DYSREGULATION; IMMUNE RESPONSE; IMMUNOSTIMULATION; INTESTINE MUCOSA; MALE; MONONUCLEAR CELL; MUCOSA CELL; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TH1 CELL; UPREGULATION;

BIOPSY; CROHN DISEASE; FLOW CYTOMETRY; GALECTINS; HUMANS; INTESTINAL MUCOSA; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TH1 CELLS; UP-REGULATION;

EID: 79955948153     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2011.568518     Document Type: Article

References (38)

1. Mayer L. Evolving paradigms in the pathogenesis of IBD. J Gastroenterol 2010;45:9-16.
2. Mizoguchi A, Mizoguchi E. Inflammatory bowel disease, past, present and future: lessons from animal models. J Gastroenterol 2008;43:1-17. (Pubitemid 351324980)
3. Engel MA, Neurath MF. New pathophysiological insights and modern treatment of IBD. J Gastroenterol 2010;45: 571-83.
4. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998;115:182-205. (Pubitemid 28307304)
5. Abraham C, Cho J. Interleukin-23/Th17 pathways and inflammatory bowel disease. Inflamm Bowel Dis 2009;15: 1090-100.
6. Kobayashi T, Okamoto S, Hisamatsu T, Kamada N, Chinen H, Saito R, et al. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease. Gut 2008;57:1682-9.
7. Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H, Chernova T, et al. Th1-specific cell surface protein Tim-3- regulates macrophage activation and severity of an autoimmune disease. Nature 2002;415:536-41. (Pubitemid 34130609)
8. Sabatos CA, Chakravarti S, Cha E, Schubart A, Sánchez- Fueyo A, Zheng XX, et al. Interaction of Tim-3 and Tim-3- ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat Immunol 2003;4:1102-10. (Pubitemid 37428038)
9. Sánchez-Fueyo A, Tian J, Picarella D, Domenig C, Zheng XX, Sabatos CA, et al. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol 2003;4: 1093-101. (Pubitemid 37428037)
10. Anderson AC, Anderson DE, Bregoli L, Hastings WD, Kassam N, Lei C, et al. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 2007;318:1141-3. (Pubitemid 350134897)
11. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005;201:233-40. (Pubitemid 40189432)
12. Harrington LE, Mangan PR, Weaver CT. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol 2006;18:349-56.
13. Yagi Y, Andoh A, Inatomi O, Tsujikawa T, Fujiyama Y. Inflammatory responses induced by interleukin-17 family members in human colonic subepithelial myofibroblasts. J Gastroenterol 2007;42:746-53. (Pubitemid 47456762)
14. Sutton C, Brereton C, Keogh B, Mills KH, Lavelle EC. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J Exp Med 2006;203:1685-91. (Pubitemid 44036274)
15. Hirota K, Hashimoto M, Yoshitomi H, Tanaka S, Nomura T, Yamaguchi T, et al. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J Exp Med 2007;204: 41-7. (Pubitemid 46148754)
16. Chen Y, Langrish CL, McKenzie B, Joyce-Shaikh B, Stumhofer JS, McClanahan T, et al. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest 2006;116: 1317-26.
17. Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, Khoury SJ, et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 2005;6: 1245-52. (Pubitemid 43045636)
18. Zhu C, Anderson AC, Kuchroo VK. TIM-3 and its regulatory role in immune responses. Curr Top Microbiol Immunol 2010. [Epub ahead of print].
19. Koguchi K, Anderson DE, Yang L, O'Connor KC, Kuchroo VK, Hafler DA. Dysregulated T cell expression of TIM3 in multiple sclerosis. J Exp Med 2006;203: 1413-18. (Pubitemid 43877603)
20. Wang Y, Meng J, Wang X, Liu S, Shu Q, Gao L, et al. Expression of human TIM-1 and TIM-3 on lymphocytes from systemic lupus erythematosus patients. Scand J Immunol 2008;67:63-70. (Pubitemid 350209587)
21. Li X, Chen G, Li Y, Wang R, Wang L, Lin Z, et al. Involvement of T cell Ig Mucin-3 (Tim-3) in the negative regulation of inflammatory bowel disease. Clin Immunol 2010;134:169-77.
22. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976;70: 439-44.
23. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987; 317:1625-9. (Pubitemid 18010466)
24. Khademi M, Illés Z, Gielen AW, Marta M, Takazawa N, Baecher-Allan C, et al. T cell Ig- and mucin-domaincontaining molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis. J Immunol 2004;172:7169-76. (Pubitemid 38669161)
25. Anderson AC, Lord GM, Dardalhon V, Lee DH, Sabatos- Peyton CA, Glimcher LH, et al. T-bet, a Th1 transcription factor regulates the expression of Tim-3. Eur J Immunol 2010;40:859-66.
26. Windhagen A, Newcombe J, Dangond F, Strand C, Woodroofe MN, Cuzner ML, et al. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J Exp Med 1995;182:1985-96.
27. Hastings WD, Anderson DE, Kassam N, Koguchi K, Greenfield EA, Kent SC, et al. TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines. Eur J Immunol 2009;39:2492-501.
28. Modlin RL. Th1-Th2 paradigm: insights from leprosy. J Invest Dermatol 1994;102:828-32. (Pubitemid 24210374)
29. Salgame P, Abrams JS, Clayberger C, Goldstein H, Convit J, Modlin RL, et al. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 1991; 254:279-82. (Pubitemid 21917341)
30. Allen JE, Maizels RM. Th1-Th2: reliable paradigm or dangerous dogma? Immunol Today 1997;18:387-92. (Pubitemid 27315712)
31. Rook G. Th1- or Th2-cell commitment during infectious disease: an oversimplification? Trends Immunol 2001;22: 481-2. (Pubitemid 32778574)
32. Imaizumi T, Kumagai M, Sasaki N, Kurotaki H, Mori F, Seki M, et al. Interferon-gamma stimulates the expression of galectin-9 in cultured human endothelial cells. J Leukoc Biol 2002;72:486-91.
33. Dardalhon V, Anderson AC, Karman J, Apetoh L, Chandwaskar R, Lee DH, et al. Tim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b +Ly-6G+ myeloid cells. J Immunol 2010;185:1383-92.
34. Noguchi A, Watanabe K, Narumi S, Yamagami H, Fujiwara Y, Higuchi K, et al. The production of interferongamma- inducible protein 10 by granulocytes and monocytes is associated with ulcerative colitis disease activity. J Gastroenterol 2007;42:947-56.
35. Wada J, Kanwar YS. Identification and characterization of galectin-9, a novel beta-galactoside-binding mammalian lectin. J Biol Chem 1997;272:6078-86. (Pubitemid 27102450)
36. Freeman GJ, Casasnovas JM, Umetsu DT, DeKruyff RH. TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity. Immunol Rev 2010;235:172-89.
37. Liu Y, Shu Q, Gao L, Hou N, Zhao D, Liu X, et al. Increased Tim-3 expression on peripheral lymphocytes from patients with rheumatoid arthritis negatively correlates with disease activity. Clin Immunol 2010;137:288-95.
38. Du WT, Zhao HF, Xu JH, Gu DS, Xue F, Ge J, et al. The role of T-cell immunoglobulin- and mucin-domaincontaining molecule-3 polymorphisms in idiopathic thrombocytopenic purpura. Hum Immunol 2009;70:398-402.